2.97
price up icon4.58%   0.13
after-market Dopo l'orario di chiusura: 2.96 -0.01 -0.34%
loading
Precedente Chiudi:
$2.84
Aprire:
$2.84
Volume 24 ore:
6.29M
Relative Volume:
0.96
Capitalizzazione di mercato:
$598.82M
Reddito:
$116.33M
Utile/perdita netta:
$-209.25M
Rapporto P/E:
-1.4009
EPS:
-2.12
Flusso di cassa netto:
$-135.49M
1 W Prestazione:
+9.59%
1M Prestazione:
+12.08%
6M Prestazione:
+197.18%
1 anno Prestazione:
+45.59%
Intervallo 1D:
Value
$2.80
$3.01
Intervallo di 1 settimana:
Value
$2.73
$3.11
Portata 52W:
Value
$0.6925
$3.94

Esperion Therapeutics Inc Stock (ESPR) Company Profile

Name
Nome
Esperion Therapeutics Inc
Name
Telefono
734-887-3903
Name
Indirizzo
3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI
Name
Dipendente
304
Name
Cinguettio
@esperioninc
Name
Prossima data di guadagno
2025-03-04
Name
Ultimi documenti SEC
Name
ESPR's Discussions on Twitter

Confronta ESPR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
ESPR
Esperion Therapeutics Inc
2.97 657.81M 116.33M -209.25M -135.49M -2.12
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.09 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.44 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.27 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.48 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
445.43 19.53B 3.08B 1.24B 1.07B 25.61

Esperion Therapeutics Inc Stock (ESPR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-18 Iniziato Goldman Neutral
2024-12-17 Iniziato Cantor Fitzgerald Overweight
2024-06-20 Downgrade BofA Securities Neutral → Underperform
2024-01-03 Downgrade BofA Securities Buy → Neutral
2023-11-20 Ripresa JP Morgan Neutral
2023-08-01 Aggiornamento Northland Capital Under Perform → Market Perform
2023-06-15 Aggiornamento BofA Securities Underperform → Buy
2023-03-16 Downgrade BofA Securities Neutral → Underperform
2023-03-16 Downgrade Northland Capital Market Perform → Under Perform
2023-03-07 Aggiornamento Credit Suisse Underperform → Neutral
2023-02-27 Ripresa BofA Securities Neutral
2023-02-24 Aggiornamento Jefferies Hold → Buy
2023-02-03 Aggiornamento Morgan Stanley Underweight → Equal-Weight
2022-08-03 Downgrade Credit Suisse Neutral → Underperform
2022-05-05 Aggiornamento JP Morgan Underweight → Neutral
2022-03-10 Iniziato H.C. Wainwright Buy
2021-10-19 Downgrade Credit Suisse Outperform → Neutral
2021-10-14 Downgrade Morgan Stanley Equal-Weight → Underweight
2021-05-05 Downgrade Stifel Buy → Hold
2021-04-26 Ripresa Credit Suisse Outperform
2021-03-11 Iniziato Morgan Stanley Equal-Weight
2021-02-12 Downgrade Jefferies Buy → Hold
2021-02-09 Downgrade Goldman Neutral → Sell
2021-01-15 Downgrade BofA Securities Buy → Neutral
2020-11-10 Aggiornamento Credit Suisse Neutral → Outperform
2020-09-29 Ripresa JP Morgan Underweight
2020-08-11 Downgrade Credit Suisse Outperform → Neutral
2020-04-01 Ripresa BofA/Merrill Buy
2020-03-17 Aggiornamento Citigroup Neutral → Buy
2020-02-24 Downgrade Northland Capital Outperform → Market Perform
2020-02-14 Downgrade Citigroup Buy → Neutral
2019-09-16 Aggiornamento Goldman Sell → Neutral
2019-05-29 Downgrade Goldman Neutral → Sell
2019-05-06 Aggiornamento BofA/Merrill Underperform → Neutral
2019-04-26 Aggiornamento Goldman Sell → Neutral
2019-03-13 Aggiornamento JP Morgan Underweight → Neutral
2019-01-07 Reiterato Needham Strong Buy
2018-12-13 Iniziato Goldman Sell
2018-10-29 Aggiornamento Northland Capital Market Perform → Outperform
2018-10-16 Iniziato BTIG Research Buy
2018-08-17 Aggiornamento Citigroup Neutral → Buy
2018-07-11 Downgrade Northland Capital Outperform → Market Perform
2018-05-03 Downgrade JP Morgan Neutral → Underweight
2018-05-02 Downgrade BofA/Merrill Buy → Underperform
Mostra tutto

Esperion Therapeutics Inc Borsa (ESPR) Ultime notizie

pulisher
06:52 AM

Why analysts remain bullish on Esperion Therapeutics Inc. stockWeekly Loss Report & Real-Time Volume Analysis - newser.com

06:52 AM
pulisher
06:49 AM

Can volume confirm reversal in Esperion Therapeutics Inc.July 2025 Intraday Action & Verified Swing Trading Watchlists - newser.com

06:49 AM
pulisher
06:44 AM

Should you wait for a breakout in Esperion Therapeutics Inc.Trade Risk Assessment & Smart Allocation Stock Tips - newser.com

06:44 AM
pulisher
06:25 AM

Is Esperion Therapeutics Inc. stock reversal real or fake2025 Market WrapUp & Accurate Buy Signal Alerts - newser.com

06:25 AM
pulisher
05:59 AM

Multi asset correlation models including Esperion Therapeutics Inc.July 2025 Drop Watch & Growth Focused Stock Reports - newser.com

05:59 AM
pulisher
05:53 AM

Will Esperion Therapeutics Inc. stock gain from lower inflationJuly 2025 Weekly Recap & Fast Exit and Entry Strategy Plans - newser.com

05:53 AM
pulisher
05:41 AM

Esperion Therapeutics (ESPR) to Release Quarterly Earnings on Thursday - MarketBeat

05:41 AM
pulisher
05:20 AM

Why Esperion Therapeutics Inc. stock is favored by top institutions2025 Analyst Calls & Smart Allocation Stock Reports - newser.com

05:20 AM
pulisher
05:17 AM

Can Esperion Therapeutics Inc. stock deliver surprise earnings beat2025 Technical Patterns & Safe Capital Preservation Plans - newser.com

05:17 AM
pulisher
05:02 AM

Why Esperion Therapeutics Inc. is moving todayLong Setup & Risk Controlled Swing Alerts - newser.com

05:02 AM
pulisher
04:37 AM

Will Esperion Therapeutics Inc. (0ET) stock benefit from mergersEarnings Growth Summary & Low Drawdown Investment Ideas - newser.com

04:37 AM
pulisher
04:31 AM

Will earnings trigger a reversal in Esperion Therapeutics Inc.Weekly Trade Recap & Weekly Breakout Watchlists - newser.com

04:31 AM
pulisher
04:30 AM

Why analysts raise outlook for Esperion Therapeutics Inc. (0ET) stockMarket Activity Report & Free Technical Confirmation Trade Alerts - newser.com

04:30 AM
pulisher
02:13 AM

Relative strength of Esperion Therapeutics Inc. in sector analysisEarnings Growth Report & Risk Controlled Daily Plans - newser.com

02:13 AM
pulisher
01:34 AM

Smart tools for monitoring Esperion Therapeutics Inc.’s price action2025 Market Trends & Technical Buy Zone Confirmation - newser.com

01:34 AM
pulisher
Oct 30, 2025

How to use Fibonacci retracement on Esperion Therapeutics Inc.Portfolio Performance Report & AI Enhanced Trade Execution Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Using AI based signals to follow Esperion Therapeutics Inc.Portfolio Growth Summary & Fast Gaining Stock Strategy Reports - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

How high can Esperion Therapeutics Inc. stock go2025 Earnings Surprises & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Published on: 2025-10-30 01:22:55 - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Identifying reversal signals in Esperion Therapeutics Inc.Quarterly Trade Summary & Low Drawdown Trading Strategies - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Applying Elliott Wave Theory to Esperion Therapeutics Inc.Quarterly Market Review & Community Consensus Trade Signals - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Esperion Therapeutics (NASDAQ:ESPR) Trading 7.1% HigherTime to Buy? - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

How to integrate Esperion Therapeutics Inc. into portfolio analysis toolsWeekly Volume Report & Step-by-Step Swing Trade Plans - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Published on: 2025-10-28 23:56:41 - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Esperion to Host Virtual Investor Key Opinion Leader Event Highlighting Significant Unmet Need in Statin Intolerance on Tuesday, November 11, 2025, at 2:00 p.m. ET. - The Manila Times

Oct 28, 2025
pulisher
Oct 28, 2025

How Esperion Therapeutics Inc. stock benefits from global expansion2025 Technical Patterns & Fast Entry High Yield Tips - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Esperion (NASDAQ: ESPR) sets Nov. 11, 2 p.m. ET KOL webinar on statin intolerance - Stock Titan

Oct 28, 2025
pulisher
Oct 28, 2025

Will Esperion Therapeutics Inc. stock return to pre crisis levelsWeekly Gains Summary & High Conviction Buy Zone Picks - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Can Esperion Therapeutics Inc. stock reach $100 price targetPortfolio Risk Summary & Technical Pattern Alert System - newser.com

Oct 28, 2025

Esperion Therapeutics Inc Azioni (ESPR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Esperion Therapeutics Inc Azioni (ESPR) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Looker Benjamin
General Counsel
Sep 17 '25
Sale
2.80
6,267
17,573
393,670
Koenig Sheldon L.
President and CEO
Sep 17 '25
Sale
2.79
28,427
79,254
1,518,831
Halladay Benjamin
Chief Financial Officer
Sep 17 '25
Sale
2.81
7,046
19,785
474,862
$45.46
price up icon 3.18%
$22.15
price down icon 1.86%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.19%
$10.36
price up icon 0.00%
$143.21
price up icon 3.75%
$445.43
price down icon 1.79%
Capitalizzazione:     |  Volume (24 ore):